title: Severe agranulocytosis following first infliximab infusion in Crohn's disease.
authors.forename: José Miguel
authors.initials: JM
authors.lastname: Rosales-Zábal
authors.forename: Francisco
authors.initials: F
authors.lastname: Fernández-Pérez
authors.forename: Cristóbal
authors.initials: C
authors.lastname: Albandea-Moreno
authors.forename: Francisco Miguel
authors.initials: FM
authors.lastname: Vera-Rivero
authors.forename: José María
authors.initials: JM
authors.lastname: Navarro-Jarabo
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D014057:Tomography, X-Ray Computed; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab